|
1
|
Shacter E and Weitzman SA: Chronic
inflammation and cancer. Oncology. 16:217–226. 2292002.
|
|
2
|
Balkwill F: Tumour necrosis factor and
cancer. Nat Rev Cancer. 9:361–371. 2009. View Article : Google Scholar
|
|
3
|
Karin M and Greten FR: NF-κB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005.
|
|
4
|
Luo JL, Kamata H and Karin M: IKK/NF-κB
signaling: balancing life and death - a new approach to cancer
therapy. J Clin Invest. 115:2625–2632. 2005.
|
|
5
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu L, Lu S, Tian J, et al: TWIST
expression in hypopharyngeal cancer and the mechanism of
TWIST-induced promotion of metastasis. Oncol Rep. 27:416–422.
2012.PubMed/NCBI
|
|
9
|
Yu L, Li HZ, Lu SM, et al: Down-regulation
of TWIST decreases migration and invasion of laryngeal carcinoma
Hep-2 cells by regulating the E-cadherin, N-cadherin expression. J
Cancer Res Clin Oncol. 137:1487–1493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang H, Wang HS, Zhou BH, et al:
Epithelial-mesenchymal transition (EMT) induced by TNF-α requires
AKT/GSK-3β-mediated stabilization of Snail in colorectal cancer.
PLoS One. 8:e566642013.
|
|
11
|
Techasen A, Namwat N, Loilome W, et al:
Tumor necrosis factor-α (TNF-α) stimulates the
epithelial-mesenchymal transition regulator Snail in
cholangiocarcinoma. Med Oncol. 29:3083–3091. 2012.
|
|
12
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of Snail by NF-κB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009.
|
|
13
|
Wu ST, Sun GH, Hsu CY, et al: Tumor
necrosis factor-α induces epithelial-mesenchymal transition of
renal cell carcinoma cells via a nuclear factor κB-independent
mechanism. Exp Biol Med. 236:1022–1029. 2011.
|
|
14
|
Smith RB, Apostolakis LW, Karnell LH, et
al: National Cancer Data Base report on osteosarcoma of the head
and neck. Cancer. 98:1670–1680. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lefebvre JL, Castelain B, De la Torre JC,
Delobelle-Deroide A and Vankemmel B: Lymph node invasion in
hypopharynx and lateral epilarynx carcinoma: a prognostic factor.
Head Neck Surg. 10:14–18. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eccles SA and Welch DR: Metastasis: recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu L, Li HZ, Lu SM, et al: Alteration in
TWIST expression: possible role in paclitaxel-induced apoptosis in
human laryngeal carcinoma Hep-2 cell line. Croat Med J. 50:536–542.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bates RC and Mercurio AM: Tumor necrosis
factor-α stimulates the epithelial-to-mesenchymal transition of
human colonic organoids. Mol Biol Cell. 14:1790–1800. 2003.
|
|
19
|
Takahashi E, Nagano O, Ishimoto T, et al:
Tumor necrosis factor-α regulates transforming growth
factor-β-dependent epithelial-mesenchymal transition by promoting
hyaluronan-CD44-moesin interaction. J Biol Chem. 285:4060–4073.
2010.
|
|
20
|
Balkwill F: Tumor necrosis factor or tumor
promoting factor? Cytokine Growth Factor Rev. 13:135–141. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee SO, Lou W, Hou M, de Miguel F, Gerber
L and Gao AC: Interleukin-6 promotes androgen-independent growth in
LNCaP human prostate cancer cells. Clin Cancer Res. 9:370–376.
2003.PubMed/NCBI
|
|
22
|
Yamauchi Y, Kohyama T, Takizawa H, et al:
Tumor necrosis factor-α enhances both epithelial-mesenchymal
transition and cell contraction induced in A549 human alveolar
epithelial cells by transforming growth factor-β1. Exp Lung Res.
36:12–24. 2010.
|
|
23
|
Drake JM, Strohbehn G, Bair TB, Moreland
JG and Henry MD: ZEB1 enhances transendothelial migration and
represses the epithelial phenotype of prostate cancer cells. Mol
Biol Cell. 20:2207–2217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li CW, Xia W, Huo L, et al:
Epithelial-mesenchymal transition induced by TNF-α requires
NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res.
72:1290–1300. 2012.
|
|
27
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-κB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007.
|
|
28
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-κB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008.
|
|
29
|
Kaisho T, Takeda K, Tsujimura T, et al:
IκB kinase α is essential for mature B cell development and
function. J Exp Med. 193:417–426. 2001.
|
|
30
|
Storci G, Sansone P, Mari S, et al:
TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which
imparts breast cancer cells with a stem cell-like phenotype. J Cell
Physiol. 225:682–691. 2010. View Article : Google Scholar : PubMed/NCBI
|
